Evidence map›Paper›PMID 26273507›Full record

ArticleBone research2013

New Clues that May Link Osteoporosis to the Circulating Lipid Profile.

Catalina Poiana, Valentin Radoi, Mara Carsote, John P Bilezikian

Abstract read
In one paragraph

Article in Bone research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Metabolomic biomarkers of low BMD: a systematic review.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Neuroendocrine neoplasia and bone (Review).Experimental and therapeutic medicine · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Glucocorticoids and Trabecular Bone Score.Journal of medicine and life
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Catalina Poiana"C. I. Parhon" National Institute of Endocrinology, Bucharest , Bucharest, Romania ; University of Medicine and Pharmacy "Carol Davila", Bucharest , Bucharest, Romania.
Valentin RadoiUniversity of Medicine and Pharmacy "Carol Davila", Bucharest , Bucharest, Romania.
Mara Carsote"C. I. Parhon" National Institute of Endocrinology, Bucharest , Bucharest, Romania ; University of Medicine and Pharmacy "Carol Davila", Bucharest , Bucharest, Romania.
John P BilezikianCollege of Physicians and Surgeons, Columbia University , New York, NY USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone Mineral Density (BMD) is a gold standard for the diagnosis of osteoporosis and is also important in the assessment of fracture risk. Other risk factors have been identified that together make up fracture risk assessment tools such as FRAX. Another potential factor, circulating lipids, has been suggested because of reports linking statins to fracture risk reduction. We analyzed the lipid profile in a cohort of women diagnosed with postmenopausal osteoporosis based on bone density determination: 610 women with osteoporosis (mean lumbar spine T-score -3.16±0.81, mean yrs. since menopause 15.79±8.9) were grouped according to age at evaluation (< 50 years, 51-60 years, 61-70 years, > 70 years), the presence/absence of a history of a fragility fracture, statin and/or antiresorptive drug use. There was no correlation between BMD and Body Mass Index (BMI: P>0.05, r (2)<0.02). However, when BMD was correlated with both BMI and the lipid profile (Triglycerides, Cholesterol, LDLc, HDLc), significant correlations were found in 5 cohorts: 51-60 years with fractures (n=61, r (2)=0.14, P<0.01), 61-70 years (n=201, r (2)=0.09, P<0.01) with fractures (n=88, r (2)=0.14, P<0.01) or without fractures (n=113, r (2)=0.24, P=0.02) and over 70 years (n=247, r (2)=0.11, P<0.01).

Indexed as

bone mineral densitycholesterolHDL-cholesterollipidosteoporosistriglycerides

Identifiers

PMID26273507
PMCPMC4472105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.